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ABSTRACT
This work reports a method for rapid amplification of the complete genome of equine influenza virus subtype 2 (H3N8).
A ThermoScriptTM reverse transcriptase instead of the avian myeloblastosis virus reverse transcriptase or Moloney
murine leukemia virus reverse transcriptase was used. This enzyme has demonstrated higher thermal stability and is
described as suitable to make long cDNA with a complex secondary structure. The product obtained by this method
can be cloned, used in later sequencing reactions or nested-PCR with the purpose of achieving a rapid diagnosis and
characterization of the equine influenza virus type A. This detection assay might be a valuable tool for diagnosis and
screening of field samples as well as for conducting molecular studies.
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RESUMEN
Amplificación del genoma completo del subtipo 2 del virus de la influenza equina. En este trabajo comunicamos
un método rápido que permite la amplificación del genoma completo del subtipo 2 (H3N8) del virus de la influenza
equina. Se utilizó la enzima transcriptasa reversa ThermoScriptTM en lugar de la transcriptasa reversa del virus de la
mieloblastosis aviar o la transcriptasa reversa del virus de la leucemia murina de Moloney. Esta enzima ha demostrado
tener una alta estabilidad térmica y la capacidad de hacer largas copias de ADN con una estructura secundaria
compleja. El producto obtenido por esta técnica puede ser clonado y utilizado posteriormente en reacciones de
secuenciación o de PCR anidada con la finalidad de lograr un diagnóstico rápido y la caracterización del virus de la
influenza equina tipo A. Este ensayo de detección puede llegar a ser una valiosa herramienta para el diagnóstico y el
análisis de muestras de campo, así como para la realización de estudios moleculares.
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Influenza viruses belong to the Orthomyxoviridae family
and are classified into three great types: A, B, and C,
according to antigenic differences in their nucleoprotein
(NP) and matrix (M) proteins. Influenza viruses types B
and C are predominantly human pathogens that have also
been isolated from seals and pigs, respectively. On the
other hand influenza viruses type A have been isolated
from many species including humans, pigs, horses, mar-
ine mammals and a wide range of domestic and wild birds
(10). Influenza viruses type A can be further subdiv-
ided in different serologically differentiated subtypes
according to the structure and composition of two antigenic
glycoproteins located in the surface of the virion: haemag-
glutinin (HA) involved in binding of the virus to host cells
and neuraminidase (NA) implicated in release of virus
from infected cells. At present, 16 HA and 9 NA subtypes
have been identified among influenza A viruses. All these
subtypes are found in avian species. However, only two
equine influenza virus subtypes have been associated
with the disease in horses, the H7N7 subtype (equi-1)
and the H3N8 subtype (equi-2). The H7N7 subtype was
first isolated from horses in Czechoslovakia in 1956 (pro-
totype strain: A/equine1/Prague/56); later it was isolated
in many countries of Europe and America. Although this
subtype has not been isolated since 1980, it may still cir-
culate in subclinical form and persist at very low levels in
some parts of the world (10). The H3N8 subtype of equine
influenza virus was first isolated in 1963 during an out-
break of this disease in Miami (prototype strain: A/equine2/
Miami/63) and can be found in different parts of the world,
except in Australia, New Zealand, and Iceland. Recent
studies of the H3N8 subtype of equine influenza viruses
have demonstrated that these strains have diverged into
two distinct evolutionary lineages (2).
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The genome of equine influenza A virus contains eight
linear segments of negative stranded RNA (about 13.6
kb). Six segments code for single proteins: the three viral
polymerases (PA, PB1 and PB2), HA, NA and NP. The
other two segments codify two proteins, one segment for
matrix 1 and 2 (M1 and M2) and the other segment for
non-structural protein 1 (NS1) and nuclear export protein
(NEP) (5).
The analysis of virion RNA from influenza A strains
indicates that all eight RNA segments contain a common
sequence of 13 nucleotides at the 3' terminus and an-
other common sequence of 12 nucleotides at the 5' ter-
minus (3, 9). No homologies can be found among seg-
ments. On these bases, the aim of this work was to de-
velop a rapid method that allows the genetic characteriz-
ation of the whole genome of influenza virus using a proce-
dure of reverse transcription followed by the amplification
of all viral segments through polymerase chain reaction
(RT-PCR).
The standard method for diagnosis of influenza is the
isolation of influenza virus particles using embryonated
chicken eggs or Madin-Darby canine kidney cells (MDCK).
This system has the disadvantage of requiring 4-6 days
for completion. The complete genome amplification by
RT-PCR reported in this paper followed by subsequent
amplicon sequencing is a more versatile method because
it allows obtaining more detailed information about circul-
ating strains and it will help in the virus surveillance.
To amplify the influenza virus genome, two primers
based on the highly conserved non-coding sequences at
the 5´ and 3´ end present in all viral genomic segments of
influenza A virus were used, according to the consensus
sequence regions previously reported (3, 9) and widely
used to amplify the complete genome of human and avian
influenza A virus (4) and equine influenza A virus subtype
1 (1). To confirm the presence of those conserved regions
in the genome of equine influenza subtype 2, 50 different
sequences of all segments from the viral genome retrieved
from the GenBank at the National Center of Biotechnol-
ogy Information (http://www.ncbi.nlm.nih.gov) were com-
pared by multiple alignment using the CLUSTAL X (v1.8)
software.
The consensus regions were identified as suitable
sequences for use as primers in RT-PCR, and the oligo-
nucleotide primers were subsequently commercially syn-
thesized (Integrated DNA Technologies, Coralville, IA,
USA). The primers used in this work were a 12-mer primer
UFLU-S 5´AGCAAAAGCAGG 3´ and a 13-mer primer
UFLU-AS 5´AGTAGAAACAAGG 3´ (Fig. 1).
An equine influenza virus strain, A/Equine-2/La Plata/
2001 (H3N8), previously isolated in our laboratory during
the year 2001, was used. The virus was propagated in
the allantoic cavity of 11-day-old embryonated hen’s eggs
derived from a healthy flock.
Total RNA was extracted using Trizol reagent (GIBCO
BRL, Gaithersburg, MD, USA). In brief, 500 µl of allantoic
Figure 1. Alignment of non-coding terminal regions of the eight segments of Influenza A virus (A/equine-2/Kentucky/5/02. GenBank
accession numbers AY855340, AY855339, AY855338, AY855341, AY855342, AY855343, AY855344 and AY855345 respectively).
The 5´ terminus of each segment has 12 conserved nucleotides (A), and the 3´ terminus has 13 conserved nucleotides (B).
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fluid (haemagglutination titre 1:128) were mixed with 500
µl of Trizol reagent. The mixture was extracted with 220
µl of chloroform. After centrifugation at 10000 x g for 10
minutes, the RNA in the aqueous solution was precipitated
by adding an equal volume of isopropanol. The precipi-
tated RNA was collected by centrifugation at 10000 x g
for 20 minutes, washed by 70% ethanol, dissolved in 50
µl of RNAse-free water and measured by spectrophotom-
eter (SmartSpec 3000, BIO-RAD, Hercules, CA, USA).
RNA extracted from uninfected allantoic fluid was used
as negative control. Total RNA and control RNA (375.06
ng/µl and 225.52 ng/µl respectively) were used for fol-
lowing steps.
One microgram of each RNA was used to produce a
single-strand copy of DNA (ssDNA). This reaction was
carried out using the avian myeloblastosis virus (AMV)
reverse transcriptase (Promega Corporation, Madison,
WI, USA), the Moloney murine leukemia virus (M-MMLV)
reverse transcriptase (Promega) and the ThermoScript
RT-PCR System kit (Invitrogen-Life Technologies, Bue-
nos Aires, Argentina) under conditions specified by the
suppliers, using a concentration 0.5 µM of the universal
primer complementary to the conserved 3’ end of all
virus segments (UFLU-S).
The single-strand DNA (ssDNA) obtained with AMV,
M-MLV and RT-ThermoScript was used directly as tem-
plate in the PCR reaction whereas the cDNA generated
by RT-ThermoScript was additionally employed for mak-
ing a double-strand DNA copy (dsDNA) in agreement with
the supplier’s suggestion.
The second chain of DNA was synthesized using 3 µl
of ssDNA previously obtained (approximately 100 ng) in
a reaction mixture containing: 75 mM Tris-HCl (pH 8.8),
20 mM (NH4)2SO4, 0.01% Tween 20, 200 µM of each
dNTPs, 1.5 mM of MgCl2 and 0.5 µM of UFLU-AS primer
in a final volume of 24.5 µl. The mixture was incubated at
95 °C during 4 minutes, followed by the addition of 0.5 µl
(2.5 U) of Taq DNA polymerase (Fermentas Inc, Glen
Burnie, MD, USA) and it was incubated at 65 °C during
20 minutes.
The PCR reaction was performed by adding 5 µl from
the ssDNA or dsDNA to a reaction mixture containing a
final concentration of 75 mM Tris-HCl (pH 8.8), 20 mM
(NH4)2SO4, 0.01% Tween 20, 200 µM of each one of
dNTPs, 0.5 µM of each one of primers (UFLU-S and
UFLU-AS), a variable concentration of MgCl2 (1, 1.5, 2
and 2.5 mM) and variable percentages of dimethil sulfoxide
(0, 5 and 10% of DMSO) in a final volume of 49.5 µl.
The mixture was heated at 95°C during 4 minutes and
incubated with variable annealing temperatures (38, 40,
42 and 44 °C) for 2 minutes, then 0.5 µl (2.5 U) from Taq
DNA polymerase (Fermentas) were added. The amplification
program started with 1 cycle at 65 °C for 10 minutes, fol-
lowed by 40 cycles at 92 °C for 2 minutes, the same an-
nealing temperature initially used for 2 minutes, and 65 °C
for 10 minutes; the program ended with one cycle at 72 °C
for 10 minutes. The PCR product was run on agarose gel
(1.5%) at 50 V during 6 hours, and the gel was stained
with ethidium bromide and visualized with a UV transillu-
minator.
To evaluate the efficiency among reverse transcrip-
tases AMV, M-MLV and ThermoScript, a protocol was
used to amplify the whole genome of equine influenza
virus. Improved results were observed when using dsDNA
generated by ThermoScript-RT. When the ssDNA template
obtained from AMV, M-MLV and ThermoScript was used,
only a few bands could be observed in agarose gel (Fig. 2)
corresponding to small size fragments of the genome.
The optimum PCR reaction was obtained by adding 5
µl from the dsDNA to a reaction mixture containing a final
concentration of 75 mM Tris-HCl (pH 8.8), 20 mM
(NH4)2SO4, 0.01% Tween 20, 200 µM of each  dNTP, 1.5
µM of MgCl2, 0.5 µM of each primer, 10% of DMSO and
2.5 U of Taq DNA polymerase.
An improved PCR amplification was carried out by
heating the PCR mixture at 95 °C during 4 minutes, an-
Figure 2. RT-PCR using ssDNA as template: Lanes 3, 4 and 6:
amplicon obtained from AMV, M-MLV and RT-ThermoScript;
Lanes 1, 2 and 7: negative controls (RNA from uninfected allantoic
fluid) obtained from AMV, M-MLV and ThermoScript RT,
respectively. Lane 5: molecular size marker (λ EcoRI-HindIII
Marker - Promega).
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Figure 3. RT-PCR using dsDNA as template: Lane 1: molecular
size marker (λ EcoRI-HindIII Marker - Promega); Lane 2: RT-
PCR product.
nealing at 40 °C for 2 minutes and then adding 0.5 µl (2.5
U) from Taq DNA polymerase (Fermentas). The amplifi-
cation program started with 1 cycle at 65 °C for 10 min-
utes, followed by 40 cycles at 92 °C for 2 minutes, 40 °C
for 2 minutes, and 65 °C for 10 minutes and a final exten-
sion at 72 °C for 10 minutes
The eight segments of equine influenza subtype 2 were
amplified simultaneously using primers UFLU-S and
UFLU-AS (Fig. 3). No amplified DNA was observed from
the RNA negative control. Bands corresponding to basic
polymerases (PB2 and PB1, segments 1 and 2 respec-
tively) could not be clearly differentiated from each other
because they were the same size (2341 bp each). It was
followed by a band belonging to the acid polymerase (PA)
of 2233 bp, segment 4 (HA) with 1778 bp, segment 5
(NP) of 1565 bp, segment 6 (NA) with 1413 bp, segment
7 (M) of 1027 bp and, at the end, a band belonging to
segment 8 (NS) which showed an increased PCR prod-
uct amount probably due to its smaller size.
In this study, the amplification conditions for the com-
plete EIV genome were improved. The data presented in
this paper demonstrate that this method could be a help-
ful tool in the surveillance of the equine influenza virus
and appropriate for cloning the eight genomic segments,
which will facilitate large-scale EIV genome sequencing
and greatly ease systematic genetic analyses of the
virus. Adeyefa et al. (1) have described a multiplex RT-
PCR method in which 12-mer and 13-mer oligonucleotides
complementary to the conserved regions were used,
resulting in simultaneous amplification of all of the eight
RNA segments of Equine Influenza virus subtype 1. In
this work, a ThermoScript RT instead of AMV or M-MLV
RT was used to amplify the full length genome of equine
influenza virus subtype 2 (H3N8). This enzyme has higher
thermal stability and is described as suitable to make long
cDNA with complex secondary structure.
The product obtained by this method can be cloned
and used in later sequencing reactions  or nested-PCR
with the purpose of achieving a rapid diagnosis and char-
acterization of the equine influenza virus type A (1, 8).
This test is much faster than the isolation of the virus
from nasopharyngeal swabs/washings using embryonated
eggs or cell cultures and the possibility of automation will
allow handling a large number of clinical samples more
conveniently than with serological tests (7, 8).
RT-PCR might be useful in detecting inapparent, sub-
clinical infection in animals that contribute to the spread
of the virus. Accurate identification of infected animals
and inapparent carriers is essential for the control of this
disease.
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